Use of Glucose‐Lowering Drugs for Type 2 Diabetes Among Danish Care Home Residents
Authors' conclusion
GLD use for T2D among Danish care home residents is high and shows limited deintensification and potential misalignment with guideline recommendations.
Study context
- Population
- All individuals admitted to Danish care homes 2018–2023; median age 84 years (IQR 78–90), 60% women
- Participants
- 88,658 care home residents
- Outcome
- GLD use for T2D among care home residents
- Follow-up
- At admission
Methodological detailsnationwide, population-based, linked national health registries
- Nationwide
- Population-based
- Linked national health registries
Main finding
As reported in the abstract
GLD use for T2D at admission
- Residents using glucose-lowering drug (GLDs) for T2D at admission
- 13% (n = 11 101)
- Continued treatment beyond 2 years
- 84%
- Used >1 GLD class
- 43%
- Metformin use
- 70%
- Insulin use
- 36%
- Basal insulin use
- 30%
- Bolus insulin use
- 16%
Observational data: associations, not effects.
Further findings
Characteristics of GLD users at admission
- Diabetes duration, median (IQR 6.8-15)
- 12 years
- HbA1c, median (IQR 6.3-7.8), little change around admission
- 6.9%
- HbA1c, median (45-62)
- 52 mmol/mol
GLP-1 RA and SGLT2i use · 2023
- GLP-1 RA use (increased over time but remained limited)
- 13%
- SGLT2i use (increased over time but remained limited)
- 24%
- Prevalence of cardiorenal disease
- 84%
- GLP-1 RA and SGLT2i use did not differ by cardiorenal disease status
GLD initiation around admission · 3 months before admission
- Initiation spike 3 months before admission
- 36 initiators/10 000 residents
- Initiation following hospitalisation
- 63%
- Overall GLD use remained stable around admission
- Primarily bolus insulin initiated by hospital physicians
Original publication
Use of Glucose‐Lowering Drugs for Type 2 Diabetes Among Danish Care Home Residents. Diabetes Obes Metab. Published 3 September 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →